Tech Leader Slouches As Its Bread-And-Butter Drug Misses Some Views - Investor's Business Daily
- Tech Leader Slouches As Its Bread-And-Butter Drug Misses Some Views Investor's Business Daily
- Vertex Pharma misses sales estimates on weak demand for older CF treatments Yahoo Finance
- Vertex Pharmaceuticals Non-GAAP EPS of $4.08 beats by $0.11, revenue of $2.48B misses by $20M (NASDAQ:VRTX) Seeking Alpha
- Vertex: Q3 Earnings Snapshot Quartz
- Vertex Reports Third Quarter 2023 Financial Results Yahoo Finance
- View Full Coverage on Google News